Conference Paper: Phase I/II double-blind, randomized, placebo-controlled study of the novel anti-HBV agent LB80380/ANA380 in patients with chronic HBV infection.
| Title | Phase I/II double-blind, randomized, placebo-controlled study of the novel anti-HBV agent LB80380/ANA380 in patients with chronic HBV infection. |
|---|---|
| Authors | Yuen, RMF Kim, J Averett, D Wong, DKH Kim, CR Kerr, B Ngai, WS Yuen, JCH Lai, CL |
| Issue Date | 2004 |
| Citation | 55th Annual Meeting of the American Association for the Study of Liver Diseases, Boston, USA 29 Oct-2 Nov 2004 (Published in Hepatology), v. 40 n. 4 Suppl 1, p. 172A [How to Cite?] |
| dc.contributor.author | Yuen, RMF |
|---|---|
| dc.contributor.author | Kim, J |
| dc.contributor.author | Averett, D |
| dc.contributor.author | Wong, DKH |
| dc.contributor.author | Kim, CR |
| dc.contributor.author | Kerr, B |
| dc.contributor.author | Ngai, WS |
| dc.contributor.author | Yuen, JCH |
| dc.contributor.author | Lai, CL |
| dc.date.accessioned | 2010-09-25T20:46:18Z |
| dc.date.available | 2010-09-25T20:46:18Z |
| dc.date.issued | 2004 |
| dc.identifier.citation | 55th Annual Meeting of the American Association for the Study of Liver Diseases, Boston, USA 29 Oct-2 Nov 2004 (Published in Hepatology), v. 40 n. 4 Suppl 1, p. 172A [How to Cite?] |
| dc.identifier.hkuros | 105328 |
| dc.identifier.issue | 4 Suppl 1 |
| dc.identifier.spage | 172 |
| dc.identifier.uri | http://hdl.handle.net/10722/102824 |
| dc.identifier.volume | , v. 40 n. 4 Suppl 1 |
| dc.language | eng |
| dc.relation.ispartof | 55th Annual Meeting of the American Association for the Study of Liver Diseases, Boston, USA 29 Oct-2 Nov 2004 (Published in Hepatology) |
| dc.title | Phase I/II double-blind, randomized, placebo-controlled study of the novel anti-HBV agent LB80380/ANA380 in patients with chronic HBV infection. |
| dc.type | Conference_Paper |